Association Between Neutrophil-Lymphocyte Ratio and All-Cause Mortality and Cause-Specific Mortality in US Adults, 1999-2014
Overview
Affiliations
Background: Neutrophil-lymphocyte ratio (NLR) is a novel marker of inflammation. Emerging studies have evaluated the relationship of NLR with cardiovascular diseases and malignant conditions. However, rare studies regarded the association between NLR and long-term health status. This study aimed to evaluate the association of NLR with all-cause mortality and cause-specific mortality among adults in the United States.
Methods: We obtained eight cycles data of National Health and Nutrition Examination Surveys (NHANES) from 1999 to 2014, and enrolled 32328 participants after certain screening. By weighted chi-square test and linear regression analysis, we analyzed the correlation between NLR and baseline characteristics of the participants. Kaplan-Meier curves and Cox regression models were used to assess the survival relevance of NLR. We conducted stratified analysis, interaction analysis, and sensitivity analysis to robustness of our results.
Results: Participants with high NLR levels had a higher risk of death. After adjustment for baseline characteristics, the hazard ratio comparing the higher vs lower NLR levels was 1.43 (95% CI, 1.18-1.73) for all-cause mortality, 1.27 (95% CI, 0.84-1.92) for cancer mortality, and 1.44 (95% CI, 0.96-2.16) for cardiovascular disease mortality. Stratified analysis found that the observed associations between NLR levels and mortality did not differ significantly.
Conclusion: In this nationally representative cohort of US adults, higher NLR was significantly associated with an increased risk of all-cause mortality.
Ferreri D, Sutliffe J, Lopez N, Sutliffe C, Smith R, Carreras-Gallo N Curr Dev Nutr. 2024; 8(12):104497.
PMID: 39668946 PMC: 11635705. DOI: 10.1016/j.cdnut.2024.104497.
Chuang S, Liu S, Chien M, Lee C, Lee Y, Chien K Am J Prev Cardiol. 2024; 20:100869.
PMID: 39498213 PMC: 11533010. DOI: 10.1016/j.ajpc.2024.100869.
Neutrophil-to-lymphocyte ratio as a predictor of cardiovascular mortality in cancer survivors.
He Y, Liu X, Wang M, Ke H, Ge C Sci Rep. 2024; 14(1):20980.
PMID: 39251691 PMC: 11385526. DOI: 10.1038/s41598-024-72027-5.
Zhai J, Yuan B, Liu T, Mo L, Xie Y, Zhao Y Front Med (Lausanne). 2024; 11:1421497.
PMID: 39234043 PMC: 11371669. DOI: 10.3389/fmed.2024.1421497.
Inflammatory Hematological Indices, Cardiovascular Disease and Mortality: A Narrative Review.
Nascimento M, Ferreira L, Alves T, Rios D Arq Bras Cardiol. 2024; 121(7):e20230752.
PMID: 39193999 PMC: 11495820. DOI: 10.36660/abc.20230752.